On March 3, 2015, the FDA issued a Drug Safety Communication concerning Testosterone drugs. Based on published studies and expert input from an Advisory Committee meeting, the FDA concluded that there is a possible increased cardiovascular risk associated with testosterone drugs and that some studies report an increased risk of heart attack, stroke and death associated with testosterone drugs. As a result, the FDA is requiring labeling changes for all prescription testosterone drugs to reflect the potential increased risk of heart attacks and strokes from the use of testosterone products. The timing of the FDA’s announcement is noteworthy as more than 1,100 Testosterone lawsuits are pending against the manufacturers of Testosterone drugs.
At this time, the Locks Law Firm is open for business and is fully functional, despite the COVID-19 pandemic.
Most of our attorneys and staff members are working remotely and we are fully equipped to continue providing all services during this time of uncertainty. As each state's guidelines are updated, we will gradually be returning to work from our four offices. In the meantime, we would ask that you communicate with us by phone, email or fax and we will respond as quickly as possible. Please do not visit our offices at this time without first communicating with a staff member.